The role of cardiac imaging modalities in risk stratification of patients with hypertrophic cardiomyopathy

Volume: 54 Number: 4 December 1, 2015
  • Kamil Tülüce
  • Sadık Volkan Emren
  • Selcen Yakar Tülüce
  • Cemil Gürgün Cahide Soydaş Çınar
EN TR

The role of cardiac imaging modalities in risk stratification of patients with hypertrophic cardiomyopathy

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disorder. It is the most common reason of sudden cardiac death (SCD) in young athletes. Prevention of these deaths is of high concern among physicians. Patients with high risk of SCD are canditates for implantable cardioverter device therapy. Cardiac imaging modalities provide important data in risk stratification for identifying HCM patients with high risk of SCD and interpreting the data obtained by different imaging modalities is important for prevention of SCD in this population. In this review, we evaluated the role of imaging modalities and their values in risk stratification of patients with HCM.

Keywords

Details

Primary Language

Turkish

Subjects

-

Journal Section

-

Authors

Kamil Tülüce

Sadık Volkan Emren

Selcen Yakar Tülüce

Cemil Gürgün Cahide Soydaş Çınar

Publication Date

December 1, 2015

Submission Date

December 1, 2015

Acceptance Date

-

Published in Issue

Year 2015 Volume: 54 Number: 4

Vancouver
1.Kamil Tülüce, Sadık Volkan Emren, Selcen Yakar Tülüce, Cemil Gürgün Cahide Soydaş Çınar. Hipertrofik kardiyomiyopatili hastaların risk sınıflandırmasında görüntüleme yöntemlerinin yeri. EJM. 2015 Dec. 1;54(4):205-12. doi:10.19161/etd.344165

Ege Journal of Medicine enables the sharing of articles according to the Attribution-Non-Commercial-Share Alike 4.0 International (CC BY-NC-SA 4.0) license.